Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease

Detalles Bibliográficos
Autores principales: Kow, Chia Siang, Hasan, Syed Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548404/
https://www.ncbi.nlm.nih.gov/pubmed/33044704
http://dx.doi.org/10.1007/s00296-020-04715-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548404/
https://www.ncbi.nlm.nih.gov/pubmed/33044704
http://dx.doi.org/10.1007/s00296-020-04715-0

Ejemplares similares